EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineering Protein Nanoparticles Functionalized with an Immunodominant Coxiella burnetii Antigen to Generate a Q Fever Vaccine

Aaron Ramirez, Jiin Felgner, Aarti Jain, Sharon Jan, Tyler J Albin, Alexander J Badten, Anthony E Gregory, Rie Nakajima, Algimantas Jasinskas, Philip L Felgner, Amanda M Burkhardt, D Huw Davies und 1 weitere

Bioconjugate Chemistry · 20.09.2023 · 34 (9) · 1653-1666

DOI: 10.1021/acs.bioconjchem.3c00317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioconjugate Chemistry, online erschienen am 08.09.2023. Verfasst von Aaron Ramirez und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, California 90089, United States. Hauptthemen laut MEDLINE: Coxiella burnetii, Q Fever, Vaccines. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS, NIAID NIH HHS, Division of Graduate Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coxiella burnetii is the causative agent of Q fever, for which there is yet to be an FDA-approved vaccine. This bacterial pathogen has both extra- and intracellular stages in its life cycle, and therefore both a cell-mediated (i.e., T lymphocyte) and humoral (i.e., antibody) immune response are necessary for effective eradication of this pathogen. However, most proposed vaccines elicit strong responses to only one mechanism of adaptive immunity, and some can either cause reactogenicity or lack sufficient immunogenicity. In this work, we aim to apply a nanoparticle-based platform toward producing both antibody and T cell immune responses against C. burnetii. We investigated three approaches for conjugation of the immunodominant outer membrane protein antigen (CBU1910) to the E2 nanoparticle to obtain a consistent antigen orientation: direct genetic fusion, high affinity tris-NTA-Ni conjugation to polyhistidine-tagged CBU1910, and the SpyTag/SpyCatcher (ST/SC) system. Overall, we found that the ST/SC approach yielded nanoparticles loaded with the highest number of antigens while maintaining stability, enabling formulations that could simultaneously co-deliver the protein antigen (CBU1910) and adjuvant (CpG1826) on one nanoparticle (CBU1910-CpG-E2). Using protein microarray analyses, we found that after immunization, antigen-bound nanoparticle formulations elicited significantly higher antigen-specific IgG responses than soluble CBU1910 alone and produced more balanced IgG1/IgG2c ratios. Although T cell recall assays from these protein antigen formulations did not show significant increases in antigen-specific IFN-γ production compared to soluble CBU1910 alone, nanoparticles conjugated with a CD4 peptide epitope from CBU1910 generated elevated T cell responses in mice to both the CBU1910 peptide epitope and whole CBU1910 protein. These investigations highlight the feasibility of conjugating antigens to nanoparticles for tuning and improving both humoral- and cell-mediated adaptive immunity against C. burnetii.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coxiella burnetiiQ FeverVaccinesAnimalsMiceAntigens, BacterialAntibodiesEpitopes

Substanzen

Antigens, BacterialVaccinesAntibodiesEpitopes

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, California 90089, United States.

ORCID-Profile: Szu-Wen Wang

Förderung

  • NIBIB NIH HHS
  • NIAID NIH HHS
  • Division of Graduate Education
  • National Institute of Biomedical Imaging and Bioengineering
  • Defense Threat Reduction Agency

Zitieren

APA

Ramirez, A., Felgner, J., Jain, A., Jan, S., Albin, T. J., Badten, A. J., Gregory, A. E., Nakajima, R., Jasinskas, A., Felgner, P. L., Burkhardt, A. M., Davies, D. H., & Wang, S. W. (2023). Engineering Protein Nanoparticles Functionalized with an Immunodominant Coxiella burnetii Antigen to Generate a Q Fever Vaccine. Bioconjugate Chemistry, 34(9), 1653-1666. https://doi.org/10.1021/acs.bioconjchem.3c00317

Vancouver

Ramirez A, Felgner J, Jain A, Jan S, Albin TJ, Badten AJ, et al. Engineering Protein Nanoparticles Functionalized with an Immunodominant Coxiella burnetii Antigen to Generate a Q Fever Vaccine. Bioconjugate Chemistry. 2023;34(9):1653-1666. doi:10.1021/acs.bioconjchem.3c00317

BibTeX
@article{Ramirez2023,
  author = {Ramirez, Aaron and Felgner, Jiin and Jain, Aarti and Jan, Sharon and Albin, Tyler J and Badten, Alexander J and Gregory, Anthony E and Nakajima, Rie and Jasinskas, Algimantas and Felgner, Philip L and Burkhardt, Amanda M and Davies, D Huw and Wang, Szu-Wen},
  title = {Engineering Protein Nanoparticles Functionalized with an Immunodominant Coxiella burnetii Antigen to Generate a Q Fever Vaccine},
  journal = {Bioconjugate Chemistry},
  year = {2023},
  volume = {34},
  number = {9},
  pages = {1653--1666},
  doi = {10.1021/acs.bioconjchem.3c00317}
}
Kostenlos starten →